These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18676226)

  • 1. Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly.
    Wu GY; Zheng XJ; Yin CC; Jiang D; Zhu L; Liu Y; Wei L; Wang Y; Chen HS
    J Chemother; 2008 Aug; 20(4):458-67. PubMed ID: 18676226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells.
    Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG
    mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly.
    Stray SJ; Zlotnick A
    J Mol Recognit; 2006; 19(6):542-8. PubMed ID: 17006877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids.
    Deres K; Schröder CH; Paessens A; Goldmann S; Hacker HJ; Weber O; Krämer T; Niewöhner U; Pleiss U; Stoltefuss J; Graef E; Koletzki D; Masantschek RN; Reimann A; Jaeger R; Gross R; Beckermann B; Schlemmer KH; Haebich D; Rübsamen-Waigmann H
    Science; 2003 Feb; 299(5608):893-6. PubMed ID: 12574631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transbody against hepatitis B virus core protein inhibits hepatitis B virus replication in vitro.
    Wang Y; Li Y; Li N; Zhu Q; Hui L; Liu X; Han Q; Lv Y; Wang Q; Yang G; Zhou Z; Liu Z
    Int Immunopharmacol; 2015 Apr; 25(2):363-9. PubMed ID: 25676532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcellular distribution and translocation of hepatitis B virus core protein in HepG2.2.15 cells].
    Pan XB; Han JC; Wei L; Peng DD; Gao Y
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):29-32. PubMed ID: 18226340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopy.
    Rat V; Seigneuret F; Burlaud-Gaillard J; Lemoine R; Hourioux C; Zoulim F; Testoni B; Meunier JC; Tauber C; Roingeard P; de Rocquigny H
    Antiviral Res; 2019 Sep; 169():104557. PubMed ID: 31302151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model.
    Weber O; Schlemmer KH; Hartmann E; Hagelschuer I; Paessens A; Graef E; Deres K; Goldmann S; Niewoehner U; Stoltefuss J; Haebich D; Ruebsamen-Waigmann H; Wohlfeil S
    Antiviral Res; 2002 May; 54(2):69-78. PubMed ID: 12062392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein.
    Han J; Pan X; Gao Y; Weil L
    Virus Res; 2010 Jun; 150(1-2):129-34. PubMed ID: 20303370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations.
    Wang XY; Wei ZM; Wu GY; Wang JH; Zhang YJ; Li J; Zhang HH; Xie XW; Wang X; Wang ZH; Wei L; Wang Y; Chen HS
    Antivir Ther; 2012; 17(5):793-803. PubMed ID: 22668794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation.
    Yang L; Wang YJ; Chen HJ; Shi LP; Tong XK; Zhang YM; Wang GF; Wang WL; Feng CL; He PL; Xu YB; Lu MJ; Tang W; Nan FJ; Zuo JP
    Antiviral Res; 2016 Jan; 125():25-33. PubMed ID: 26611395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
    Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
    J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular-delivery of a single-chain antibody against hepatitis B core protein via cell-penetrating peptide inhibits hepatitis B virus replication in vitro.
    Xun Y; Pan Q; Tang Z; Chen X; Yu Y; Xi M; Zang G
    Int J Mol Med; 2013 Feb; 31(2):369-76. PubMed ID: 23241903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of CDK9 inhibitor FIT-039 on hepatitis B virus propagation.
    Tanaka T; Okuyama-Dobashi K; Murakami S; Chen W; Okamoto T; Ueda K; Hosoya T; Matsuura Y; Ryo A; Tanaka Y; Hagiwara M; Moriishi K
    Antiviral Res; 2016 Sep; 133():156-64. PubMed ID: 27515132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.
    Viswanathan U; Mani N; Hu Z; Ban H; Du Y; Hu J; Chang J; Guo JT
    Antiviral Res; 2020 Oct; 182():104917. PubMed ID: 32818519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein.
    Gordien E; Rosmorduc O; Peltekian C; Garreau F; Bréchot C; Kremsdorf D
    J Virol; 2001 Mar; 75(6):2684-91. PubMed ID: 11222692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
    Shaw T; Mok SS; Locarnini SA
    Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein.
    Wang J; Zhang H; Zhang Y; Jiang D; Li J; Goldmann S; Ren Q; Fei R; Wang X; Wei L
    J Med Virol; 2017 Oct; 89(10):1804-1810. PubMed ID: 28401569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways.
    Guo F; Zhao Q; Sheraz M; Cheng J; Qi Y; Su Q; Cuconati A; Wei L; Du Y; Li W; Chang J; Guo JT
    PLoS Pathog; 2017 Sep; 13(9):e1006658. PubMed ID: 28945802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virus.
    Asif-Ullah M; Choi KJ; Choi KI; Jeong YJ; Yu YG
    Antiviral Res; 2006 Jun; 70(2):85-90. PubMed ID: 16487605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.